Current trends and future prospects of lipstatin: a lipase inhibitor and pro-drug for obesity

No abstract is available for this paper.

• Publication year

  2015

• Venue

  RSC Advances

• Publication date

  2015-10-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1039/C5RA14892H
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Obesity: A new paradigm for treating obesity and diabetes mellitus

  2015cited by this paper
• Identification of Lipstatin-Producing Ability in Streptomyces virginiae CBS 314.55 Using Dereplication Approach

  2014cited by this paper
• Operon for Biosynthesis of Lipstatin, the Beta-Lactone Inhibitor of Human Pancreatic Lipase

  2014cited by this paper
• Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes.

  2014cited by this paper
• Enhanced production of lipstatin from Streptomyces toxytricini by optimizing fermentation conditions and medium.

  2014cited by this paper
• Peripheral targets in obesity treatment: a comprehensive update

  2014cited by this paper
• New and Emerging Drug Molecules Against Obesity

  2014cited by this paper
• A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

  2014cited by this paper
• Mechanisms of Obesity-Induced Inflammation and Insulin Resistance: Insights into the Emerging Role of Nutritional Strategies

  2013cited by this paper
• Inhibition of pancreatic lipase, α-glucosidase, α-amylase, and hypolipidemic effects of the total flavonoids from Nelumbo nucifera leaves.

  2013cited by this paper
• Molecules Best Paper Award 2013

  2013cited by this paper
• Safety of antiobesity drugs

  2013cited by this paper
• Functional Analysis of Seven Genes Linked to Body Mass Index and Adiposity by Genome-Wide Association Studies: A Review

  2013cited by this paper
• Causes of obesity

  2012cited by this paper
• MEDIUM OPTIMIZATION OF LIPSTATIN FROM Streptomyces toxytricini ATCC 19813 BY SHAKE FLASK STUDY

  2012cited by this paper
• Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study

  2012cited by this paper
• Anti-obesity drugs: past, present and future

  2012cited by this paper
• Polyphenols extracted from black tea (Camellia sinensis) residue by hot-compressed water and their inhibitory effect on pancreatic lipase in vitro.

  2012cited by this paper
• Toxicity of Weight Loss Agents

  2012cited by this paper
• Biochemical characteristization of propionyl-coenzyme a carboxylase complex of Streptomyces toxytricini

  2011cited by this paper
• Natural Inhibitors of Pancreatic Lipase as New Players in Obesity Treatment

  2011cited by this paper
• Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats

  2010cited by this paper
• Weight Loss, HbA1c Reduction, and Tolerability of Cetilistat in a Randomized, Placebo‐controlled Phase 2 Trial in Obese Diabetics: Comparison With Orlistat (Xenical)

  2010cited by this paper
• Lethal thyroid storm after uncontrolled intake of liothyronine in order to lose weight

  2010cited by this paper
• Optimal Extraction Conditions of Anti-obesity Lipase Inhibitor from Phellinus linteus and Nutritional Characteristics of the Extracts

  2010cited by this paper
• The role of acyl-coenzyme A carboxylase complex in lipstatin biosynthesis of Streptomyces toxytricini

  2010cited by this paper
• Pharmacological management of appetite expression in obesity

  2010cited by this paper
• Maté Tea Inhibits In Vitro Pancreatic Lipase Activity and Has Hypolipidemic Effect on High‐fat Diet‐induced Obese Mice

  2010cited by this paper
• Current and Future Drug Targets in Weight Management

  2010cited by this paper
• Impact of environmental endocrine disrupting chemicals on the development of obesity

  2010cited by this paper
• Screening for Cushing’s Syndrome in Obese Patients

  2010cited by this paper
• Appetite suppressants, cardiac valve disease and combination pharmacotherapy.

  2009cited by this paper
• Review Paper: Current Strategies in the Development of Anti-obesity Drugs and Their Safety Concerns

  2009cited by this paper
• The effects of diet and orlistat on body weight and lipid profiles in high risk Chinese patients with coronary artery disease, obesity and hypercholesterolemia

  2009cited by this paper
• Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver

  2009cited by this paper
• Life Science : Identification and Characterization of Acetyl-CoA Carboxylase Gene Cluster in Streptomyces toxytricini

  2009cited by this paper
• Annual medical spending attributable to obesity: payer-and service-specific estimates.

  2009cited by this paper
• Abdominal Subcutaneous Adipose Tissue: A Protective Fat Depot?

  2009cited by this paper
• Screening of selected food and medicinal plant extracts for pancreatic lipase inhibition

  2009cited by this paper
• Antiobesity action of a daidzein derivative on male obese mice induced by a high-fat diet.

  2009cited by this paper
• Oleanane-type triterpene oligoglycosides with pancreatic lipase inhibitory activity from the pericarps of Sapindus rarak.

  2009cited by this paper
• Fat distribution in men of different waist girth, fitness level and exercise habit

  2009cited by this paper
• Common genetic variation near MC4R is associated with waist circumference and insulin resistance

  2008cited by this paper
• Pancreatic lipase inhibitory activity of taraxacum officinale in vitro and in vivo

  2008cited by this paper
• CB1 Receptor Blockade and its Impact on Cardiometabolic Risk Factors: Overview of the RIO Programme with Rimonabant

  2008cited by this paper
• Bypassing Medicine to Treat Diabetes

  2008cited by this paper
• Putative environmental-endocrine disruptors and obesity: a review

  2008cited by this paper
• AMPK and PPARd Agonists Are Exercise Mimetics

  2008cited by this paper
• Antiobese effects of novel saponins from edible seeds of Japanese horse chestnut (Aesculus turbinata BLUME) after treatment with wood ashes.

  2008cited by this paper
• Update on obesity.

  2008cited by this paper
• Surgical treatment of obesity.

  2008cited by this paper
• Saponins (Ginsenosides) from stems and leaves of Panax quinquefolium prevented high-fat diet-induced obesity in mice.

  2008cited by this paper
• The exercise pill--too good to be true?

  2008cited by this paper
• The leptin hypothesis of depression: a potential link between mood disorders and obesity?

  2007cited by this paper
• Weight gain reduction in mice fed Panax ginseng saponin, a pancreatic lipase inhibitor.

  2007cited by this paper
• Pancreatic lipase-inhibiting triterpenoid saponins from Gypsophila oldhamiana.

  2007cited by this paper
• Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study

  2007cited by this paper
• Pharmacological Treatment of the Overweight Patient

  2007cited by this paper
• overweight: updated meta-analysis Long term pharmacotherapy for obesity and

  2007cited by this paper
• The Safety Profiles of Orlistat and Sibutramine: Results of Prescription‐Event Monitoring Studies in England

  2007cited by this paper
• Development of inhibitors against lipase and α‐glucosidase from derivatives of monascus pigment

  2007cited by this paper
• Oligomeric procyanidins in apple polyphenol are main active components for inhibition of pancreatic lipase and triglyceride absorption.

  2007cited by this paper
• Obesity and Polycystic Ovary Syndrome

  2007cited by this paper
• Why is the developed world obese?

  2007cited by this paper
• 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]

  2007cited by this paper
• Assessment of obesity and its clinical implications

  2006cited by this paper
• Bmc Complementary and Alternative Medicine Inhibitory Effect of Green Coffee Bean Extract on Fat Accumulation and Body Weight Gain in Mice

  2006cited by this paper
• Inflammation and metabolic disorders

  2006cited by this paper
• Abdominal obesity and metabolic syndrome

  2006cited by this paper
• Effects of Arachis hypogaea nutshell extract on lipid metabolic enzymes and obesity parameters.

  2006cited by this paper
• Role of Adipokines in the Obesity–Inflammation Relationship: The Effect of Fat Removal

  2006cited by this paper
• The obesity epidemic and its cardiovascular consequences

  2006cited by this paper
• Vibralactone: a lipase inhibitor with an unusual fused beta-lactone produced by cultures of the basidiomycete Boreostereum vibrans.

  2006cited by this paper
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase.

  2006cited by this paper
• Lupane-type saponins from leaves of Acanthopanax sessiliflorus and their inhibitory activity on pancreatic lipase.

  2006cited by this paper
• Visceral Fat Is an Independent Predictor of All‐cause Mortality in Men

  2006cited by this paper
• Bmc Complementary and Alternative Medicine Anti-obesity Effects of Chikusetsusaponins Isolated from Panax Japonicus Rhizomes

  2005cited by this paper
• Meta-Analysis: Pharmacologic Treatment of Obesity

  2005cited by this paper
• Absence of ghrelin protects against early-onset obesity.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Exercise in a pill: feasibility of energy expenditure targets.

  2004cited by this paper
• XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

  2004cited by this paper
• Obesity and cancer

  2004cited by this paper
• The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome.

  2004cited by this paper
• Importance of Adipocytokines in Obesity-Related Diseases

  2003cited by this paper
• Anti-obesity Effect of Dioscorea nipponica Makino with Lipase-inhibitory Activity in Rodents

  2003cited by this paper
• Endocrine disruptors and the obesity epidemic.

  2003cited by this paper
• Chemical Toxins: A Hypothesis to Explain the Global Obesity Epidemic

  2002cited by this paper
• The triglyceride lipases of the pancreas Published, JLR Papers in Press, October 1, 2002. DOI 10.1194/jlr.R200012-JLR200

  2002cited by this paper
• Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes.

  2002cited by this paper
• Reduction of Inflammatory Cytokine Concentrations and Improvement of Endothelial Functions in Obese Women After Weight Loss Over One Year

  2002cited by this paper
• Kinetic and Structural Analysis of a New Group of Acyl-CoA Carboxylases Found in Streptomyces coelicolor A3(2)*

  2002cited by this paper
• Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults.

  2002cited by this paper
• Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia.

  2002cited by this paper
• Salacia reticulata and its polyphenolic constituents with lipase inhibitory and lipolytic activities have mild antiobesity effects in rats.

  2002cited by this paper
• RANDOMISED TRIAL OF THE EFFECT OF ORLISTAT ON BODY WEIGHT AND CARDIOVASCULAR DISEASE RISK PROFILE IN OBESE PATIENTS: UK MULTIMORBIDITY STUDY

  2002cited by this paper
• Bulletin of the World Health Organization

  2001cited by this paper
• Behavioral science research in diabetes: lifestyle changes related to obesity, eating behavior, and physical activity.

  2001cited by this paper
• Guar gum for body weight reduction: meta-analysis of randomized trials.

  2001cited by this paper

• Impact of Orlistat on Staphylococcus aureus Engulfment by Phagocytic Cells In Vitro

  2025cites this paper
• Anti-Obesity Potentials of Methanol Extracts of Phragmanthera Incana Leaves Hemi-Parasitic on Guava, Cashew, Kolanut and Mango Trees in High-Fat Diet-Induced Obese Rats

  2024cites this paper
• Covalent drug – An emerging framework for targeted drug development

  2024cites this paper
• Cryptic enzymatic assembly of peptides armed with β-lactone warheads

  2024cites this paper
• Insights into the mechanism of mycelium transformation of Streptomyces toxytricini into pellet

  2023cites this paper
• Biopanning, Heterologous Expression, and Characterization of a Shark-Derived Single-Domain Antibody Fusion Protein against Pancreatic Lipase.

  2023cites this paper
• Inhibitory activities of grape bioactive compounds against enzymes linked with human diseases

  2022cites this paper
• A system biology approach for engineering non-oxidative glycolysis pathway in Streptomyces toxytricini for high lipstatin biosynthesis

  2022cites this paper
• Bacterial bioactive metabolites as therapeutic agents: From production to action

  2022cites this paper
• Potato extract inhibits lipase activity and ameliorates gut microbiome dysbiosis and weight gain in mice fed a high-fat diet

  2021cites this paper
• Pre-Clinical Evidence for the Anti-Obesity Potential of Quercetin and Curcumin Loaded Chitosan/PEG Blended PLGA Nanoparticles

  2021influential citation
• Pancreatic lipase inhibitors: The road voyaged and successes.

  2021cites this paper
• Dihydromyricetin Imbues Antiadipogenic Effects on 3T3-L1 Cells via Direct Interactions with 78-kDa Glucose-Regulated Protein.

  2021cites this paper
• Prominent and emerging anti-diabetic molecular targets

  2020cites this paper
• Bryophyllum Pinnatum: A Review on Medicinal Benefits and Potent Bioactive Molecules

  2020cites this paper
• Enhanced production of lipstatin from mutant of Streptomyces toxytricini and fed-batch strategies under submerged fermentation

  2020cites this paper
• Exploring Aurone Derivatives as Potential Human Pancreatic Lipase Inhibitors through Molecular Docking and Molecular Dynamics Simulations

  2020cites this paper
• Six types of tea reduce high-fat-diet-induced fat accumulation in mice by increasing lipid metabolism and suppressing inflammation.

  2019cites this paper
• Potential Anti-obesity Effects of some Medicinal Herb: In vitro α-Amylase, α-Glucosidase and Lipase Inhibitory Activity

  2019cites this paper
• MetaMed: Linking Microbiota Functions with Medicine Therapeutics

  2019cites this paper
• Characterization of Lipstatin and the Minor Components from Streptomyces toxytricini Fermentation Broth by HPLC–ESI–Q-TOF–MS

  2019cites this paper
• Citric Acid Cycle Regulation: Back Bone for Secondary Metabolite Production

  2019cites this paper
• Enzyme Engineering

  2019cites this paper
• Understanding Process Variables and their Interactions for Maximizing Production of Artemisinin Derivative Artemether (Anti-Malarial Drug) Through Cunninghamella echinulata var elegans at 5 L Bioreactor Level

  2019cites this paper
• Diversifying of Chemical Structure of Native Monascus Pigments

  2018cites this paper
• Rh-Catalyzed Conjugate Addition of Aryl and Alkenyl Boronic Acids to α-Methylene-β-lactones: Stereoselective Synthesis of trans-3,4-Disubstituted β-Lactones.

  2017cites this paper
• Mycelium transformation of Streptomyces toxytricini into pellet: Role of culture conditions and kinetics.

  2017cites this paper
• Implication of mutagenesis and precursor supplementation towards the enhancement of lipstatin (an antiobesity agent) biosynthesis through submerged fermentation using Streptomyces toxytricini

  2017cites this paper
• Modulation of fatty acid metabolism and tricarboxylic acid cycle to enhance the lipstatin production through medium engineering in Streptomyces toxytricini.

  2016cites this paper
• Current Trends and Future Prospects of Lipstatin: A Lipase Inhibitor and Pro-Drug for Obesity.

  2015cites this paper